驾驭不断变化的 HFpEF 管理：ACC/AHA/ESC 主要指南更新详解。

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine Pub Date : 2024-11-01 DOI:10.1016/j.carrev.2024.04.004

Niyati Grewal , Jaspreet Singh Grewal , Mohammed Aldhaeefi , Prafulla P. Mehrotra , Urooj Fatima

{"title":"驾驭不断变化的 HFpEF 管理：ACC/AHA/ESC 主要指南更新详解。","authors":"Niyati Grewal , Jaspreet Singh Grewal , Mohammed Aldhaeefi , Prafulla P. Mehrotra , Urooj Fatima","doi":"10.1016/j.carrev.2024.04.004","DOIUrl":null,"url":null,"abstract":"<div><div><span>Heart failure, a growing concern in the United States, significantly impacts both morbidity and mortality. Classified by ejection fraction, </span>heart failure with preserved ejection fraction<span> (HFpEF) now accounts for half of all cases and is steadily rising. Unlike its counterpart, heart failure with reduced ejection fraction (HFrEF), HFpEF lacks clear management guidelines. Recognizing this critical gap, we aim to review existing recommendations and formulate effective management strategies for HFpEF.</span></div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"68 ","pages":"Pages 79-85"},"PeriodicalIF":1.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Navigating the evolving landscape of HFpEF management: A detailed look at key ACC/AHA/ESC guideline updates\",\"authors\":\"Niyati Grewal , Jaspreet Singh Grewal , Mohammed Aldhaeefi , Prafulla P. Mehrotra , Urooj Fatima\",\"doi\":\"10.1016/j.carrev.2024.04.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><span>Heart failure, a growing concern in the United States, significantly impacts both morbidity and mortality. Classified by ejection fraction, </span>heart failure with preserved ejection fraction<span> (HFpEF) now accounts for half of all cases and is steadily rising. Unlike its counterpart, heart failure with reduced ejection fraction (HFrEF), HFpEF lacks clear management guidelines. Recognizing this critical gap, we aim to review existing recommendations and formulate effective management strategies for HFpEF.</span></div></div>\",\"PeriodicalId\":47657,\"journal\":{\"name\":\"Cardiovascular Revascularization Medicine\",\"volume\":\"68 \",\"pages\":\"Pages 79-85\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Revascularization Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1553838924001489\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553838924001489","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

心力衰竭在美国日益受到关注，它对发病率和死亡率都有重大影响。按射血分数分类，射血分数保留型心力衰竭（HFpEF）目前占所有病例的一半，且呈稳步上升趋势。与射血分数降低型心力衰竭（HFrEF）不同，HFpEF 缺乏明确的管理指南。认识到这一关键差距，我们旨在回顾现有建议，并为 HFpEF 制定有效的管理策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Navigating the evolving landscape of HFpEF management: A detailed look at key ACC/AHA/ESC guideline updates

Heart failure, a growing concern in the United States, significantly impacts both morbidity and mortality. Classified by ejection fraction, heart failure with preserved ejection fraction (HFpEF) now accounts for half of all cases and is steadily rising. Unlike its counterpart, heart failure with reduced ejection fraction (HFrEF), HFpEF lacks clear management guidelines. Recognizing this critical gap, we aim to review existing recommendations and formulate effective management strategies for HFpEF.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

3.30

自引率

5.90%

发文量

687

审稿时长

36 days

期刊介绍： Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.